Rchr
J-GLOBAL ID：200901035576369618
Update date: Jan. 30, 2024
Harada Michishige
ハラダ ミチシゲ | Harada Michishige
Contact this researcher
You can send email directly to the researcher.
Affiliation and department：
RIKEN RIKEN Center for Integrative Medical Sciences
About RIKEN RIKEN Center for Integrative Medical Sciences
Search "RIKEN RIKEN Center for Integrative Medical Sciences"
Detailed information
Research field (1)：
Immunology
Research theme for competitive and other funds (4)：
2011 - 2016 The mechanisms of development and differentiation in Valpha14 NKT cells
2009 - 2012 喘息感受性の候補遺伝子TSLPとSNPsによる発現調節
2005 - 2007 Vα14NKT細胞の産生するIL-21を介したIgE調節機構の解明
2003 - 2005 NKT細胞に発現するCD1d分子を認識する抑制性受容体の細胞傷害抑制機構
Papers (35)：
Toshitada Takemori, Akiko Sugimoto-Ishige, Hironori Nishitsuji, Yushi Futamura, Michishige Harada, Tomomi Kimura-Someya, Takehisa Matsumoto, Teruki Honma, Miho Tanaka, Masami Yaguchi, et al. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection. Journal of virology. 2022. 96. 5. e0168621
Dashtsoodol N, Shigeura T, Aihara M, Ozawa R, Kojo S, Harada M, Endo TA, Watanabe T, Ohara O, Taniguchi M. Alternative pathway for the development of V
α
14
+
NKT cells directly from CD4
-
CD8
-
thymocytes that bypasses the CD4
+
CD8
+
stage. Nature immunology. 2017. 18. 3. 274-282
Masatoshi Kanda, Hiroyuki Yamanaka, Satoshi Kojo, Yuu Usui, Hiroaki Honda, Yusuke Sotomaru, Michishige Harada, Masaru Taniguchi, Nao Suzuki, Tatsuya Atsumi, et al. Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-gamma production in iNKT cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2016. 113. 24. E3394-E3402
Nyambayar Dashtsoodol, Tomokuni Shigeura, Ritsuko Ozawa, Michishige Harada, Satoshi Kojo, Takashi Watanabe, Haruhiko Koseki, Manabu Nakayama, Osamu Ohara, Masaru Taniguchi. Generation of Novel Traj18-Deficient Mice Lacking V alpha 14 Natural Killer T Cells with an Undisturbed T Cell Receptor alpha-Chain Repertoire. PLOS ONE. 2016. 11. 4. e0153347
Masaru Taniguchi, Michishige Harada, Nyambayar Dashtsoodol, Satoshi Kojo. Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES. 2015. 91. 7. 292-304
ｍore...
MISC (72)：
Masaru Taniguchi, Shin-ichiro Fujii, Toshinori Nakayama, Shinichiro Motohashi, Nyambayar Dashtsoodol, Hiroshi Watarai, Michishige Harada. Introduction: Mechanisms of NKT-cell-mediated adjuvant activity and function of iPS-derived NKT cells. Natural Killer T cells: Balancing the Regulation of Tumor Immunity. 2012. 1-13
原田 通成, 広田 朝光, 人見 祐基, 玉利 真由美. 先端医学講座 遺伝子多型とアレルギー疾患. アレルギーの臨床. 2010. 30. 2. 164-167
原田 通成, 広田 朝光, 玉利 真由美. 気管支喘息と自然免疫関連遺伝子. 感染・炎症・免疫. 2010. 39. 4. 364-366
原田 通成, 広田 朝光, 人見 祐基, 玉利 真由美. 【アレルギー疾患の免疫機構 免疫細胞・サイトカインからみたアレルギー発症機序と治療へ向けた臨床的アプローチ】 臨床からみたアレルギー疾患 アレルゲンとアレルギー疾患 アレルギーの遺伝要因 自然免疫応答の関与. 実験医学. 2009. 27. 20. 3360-3365
原田 通成, 広田 朝光, 人見 祐基, 玉利 真由美. 【喘息の病態に関する最新の知見】 小児気管支喘息と遺伝子多型. 喘息. 2009. 22. 2. 154-158
ｍore...
Education (3)：
1997 - 2001 Chiba University
1992 - 1994 東北大学大学院 農学研究科 畜産学専攻
1988 - 1992 Tohoku University Faculty of Agriculture
Professional career (1)：
医学博士
Work history (5)：
2009/10 - 現在 RIKEN IMS
2006/03 - 2009/09 RIKEN CGM
2002/04 - 2006/02 RIKEN RCAI
2001/04 - 2002/03 Chiba University Graduate School of Medicine
1994/04 - 1997/03 生化学工業株式会社 東京研究所 研究員
Association Membership(s) (2)：
JAPANESE SOCIETY OF ALLERGOLOGY
, 日本免疫学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
